Designates the facility of the United States Postal Service located at 129 Walnut Street in Corning, New York, as the "Amory 'Amo' Houghton, Jr. Post Office Building."
Unleashing American Energy Act This bill requires a minimum amount of oil and gas lease sales a year on certain submerged lands of the Outer Continental Shelf (OCS) and limits delays on federal oil and gas leases on such lands. Specifically, this bill requires the Department of the Interior to annually conduct a minimum of two region-wide oil and gas lease sales in each of the following regions of the OCS: (1) the Gulf of Mexico region in the Central Gulf of Mexico Planning Area and the Western Gulf of Mexico Planning Area, and (2) the Alaska region. In addition, the bill requires the President to obtain congressional approval before delaying federal oil and gas leases on the OCS.
Strategy to Secure Offshore Energy Act This bill modifies requirements for the National Outer Continental Shelf Oil and Gas Leasing Program, including by specifying that the program must be updated on a five-year basis and setting a minimum number of annual lease sales for the program.
Restore Onshore Energy Production Act This bill requires the Department of the Interior to immediately resume sales of oil and gas leases in accordance with applicable onshore mineral leasing laws and specifies a minimum number of sales that Interior must conduct in each state where there is land available for oil and gas leasing. The bill also prohibits the President from taking actions to cancel, delay, or otherwise impede federal processes related to energy mineral leasing without congressional approval.
Energy Permitting Certainty Act This bill requires the Department of the Interior to process applications for permits to drill under a valid oil or gas lease even if there are any pending civil actions, provided that the civil actions do not directly affect or involve the application or underlying lease.
Promoting Energy Independence and Transparency Act This bill requires the Department of the Interior to take certain actions related to parcels of land that have been nominated for future sales of onshore oil and gas leases and related drilling permits. Specifically, Interior must (1) report to Congress about the status of the parcels, (2) publish on its website information concerning expressions of interest in nominated parcels and drilling permits, and (3) issue certain pending applications for drilling permits within 30 days.
Securing American Energy and Investing in Resiliency Act This bill requires the Department of the Interior to conduct certain sales of oil and gas leases on the Outer Continental Shelf by a specified deadline.
COVID-19 American History Project Act This bill directs the American Folklife Center at the Library of Congress to establish a history project to be known as the COVID-19 American History Project to collect and make publicly available individual stories and records of experiences during the COVID-19 pandemic in the United States. The bill includes a requirement to collect video and audio recordings of personal histories and testimonials of those who were affected by the pandemic. The Librarian of Congress may solicit and accept donations of funds and in-kind contributions to carry out the project, subject to this bill.
This resolution honors the life and legacy of the late Representative Don Young and directs the Sergeant at Arms to designate a Don Young Reserved Seat on the floor of the chamber of the House of Representatives.
Protecting o ur Pharmaceutical Supply Chain from China Act of 2022 This bill requires the federal government to maintain a registry of certain foreign-sourced drugs, prohibits federal health care programs from purchasing drugs containing ingredients manufactured in China, requires drugs to be labeled for country of origin, and offers domestic manufacturing facility tax incentives. The Food and Drug Administration shall maintain (1) a list of foreign-sourced drugs and active ingredients that are critical for consumer health and safety, and (2) another list identifying such drugs that are produced exclusively in China or use ingredients produced in China. The bill phases in a restriction on federal health care programs purchasing drugs with active ingredients manufactured in China. By January 1, 2024, such programs may not purchase a drug with any active ingredients from China. The Department of Health and Human Services may issue a waiver for an agency or program that is unable to meet this requirement, but no waiver may apply to drugs purchased in or after 2026. Each drug must have labeling listing the country of origin of each active ingredient, and a drug without this labeling shall be deemed misbranded. The bill allows 100% tax expensing for qualified pharmaceutical and medical device manufacturing property placed in service between 2020 and 2026.
